Bacille Calmette-Guérin revaccination shows no efficacy in preventing sustained Mycobacterium tuberculosis infection compared with placebo in adolescents in a phase 2b study.

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

A new study has cast a sobering light on Uganda’s immunization efforts, revealing alarmingly high levels of vaccine wastage ...

The five-year, 150-person, phase 2 trial is investigating whether repeat BCG vaccination can clinically improve type 1 diabetes in adults with existing disease and is almost fully enrolled.

BCG does not make leprosy an immunopreventable disease, in the sense that the disease cannot be controlled with the BCG vaccine alone; other measures are required, but in the light of the present ...

Puducherry has emerged as a frontrunner in Tuberculosis (TB) testing, ramping up examinations of presumptive TB patients from 2,233 per lakh population in 2015 to 2,526 per lakh in 2024, officials ...

MPs launch probe into polio, BCG vaccine distribution across the country The probe follows a nationwide shortage that has raised alarm among health professionals and lawmakers.

Sam S. Chang MD, MBA, discusses intravesical mitomycin in low-grade intermediate-risk nonmuscle-invasive bladder cancer vs ...

The Bacille Calmette–Guérin (BCG) vaccine, originally developed for tuberculosis prevention, has garnered considerable attention for its capacity to reprogramme the innate immune system. Beyond ...

The story of tuberculosis goes back to the start of recorded human history, and since the 1800s it’s estimated it has been responsible for over 1 billion deaths. In New Zealand today we don’t have ...

A Bill that proposed naming Ireland's new children's hospital after Dr. Kathleen Lynn from Killala, County Mayo, was ...

While tuberculosis is not a major health issue in New Zealand, worldwide it remains the leading infectious disease killer.  ...